サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1360312

毒性薬物検査市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

Toxicology Drug Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
毒性薬物検査市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年
出版日: 2023年08月18日
発行: Transparency Market Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

毒性薬物検査市場- レポートの範囲

世界の毒性薬物検査市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界の毒性薬物検査の収益を提供します。 2023年を基準年、2031年を予測年とみなして、2017年から2031年の期間の市場を分析します。レポートは、2023年から2031年までの世界の毒性薬物検査市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、毒性薬物検査市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値 347億米ドル
2031年の市場価値 557億米ドル
CAGR 5.5%

このレポートは、世界の毒性薬物検査市場の競合情勢を詳しく掘り下げています。世界の毒性薬物検査市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の毒性薬物検査市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017～2031年

第5章 重要な洞察

  • 技術の進歩
  • 地域/世界ごとの規制シナリオ
  • COVID-19パンデミックによる業界への影響（バリューチェーンと短期・中期・長期的な影響）

第6章 世界市場の分析と予測：テストタイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：テストタイプ別、2017-2031
    • 試験管内
    • 生体内
    • シリコ内
  • 市場魅力度分析：テストタイプ別

第7章 世界市場の分析と予測：試験方法別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：試験方法別、2017-2031
    • 質量分析イメージング
    • 電子顕微鏡法
    • 蛍光標識
    • 免疫組織化学
    • その他
  • 市場魅力度分析：試験方法別

第8章 世界市場の分析と予測：用途別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：用途別、2017-2031
    • 医薬品開発
    • 薬物乱用と中毒
    • 治療薬のモニタリング
    • その他
  • 市場魅力分析：用途別

第9章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：エンドユーザー別、2017-2031
    • 化粧品産業
    • ヘルスケア産業
      • 病院と診療所
      • 診断研究所
      • 製薬およびバイオテクノロジー企業
      • その他
    • 食品業界
    • 化学工業
  • 市場魅力度分析：エンドユーザー別

第10章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2017-2031
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場魅力度

第11章 北米市場の分析と予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋市場の分析と予測

第14章 ラテンアメリカ市場の分析と予測

第15章 中東およびアフリカ市場の分析と予測

第16章 競合情勢

  • 市場プレーヤー-競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • TDAL Labs
    • Thermo Fisher Scientific Inc.
    • Abbott
    • Icahn School of Medicine at Mount Sinai
    • Clinisys, Inc.
    • Laboratory Corporation of America Holdings
    • SLUCARE
    • Keystone Lab
    • Shimadzu Scientific Instruments
    • Ganesh Diagnostic &Imaging Centre Pvt. Ltd.
    • Other Players
図表

List of Tables

  • Table 01: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
  • Table 02: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
  • Table 03: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
  • Table 06: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
  • Table 08: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
  • Table 09: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 10: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
  • Table 12: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 13: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
  • Table 14: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
  • Table 15: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
  • Table 18: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 19: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
  • Table 20: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
  • Table 21: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 22: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 23: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
  • Table 24: Asia Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 25: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
  • Table 26: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
  • Table 27: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 28: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 29: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
  • Table 30: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 31: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Type, 2017-2031
  • Table 32: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Testing Method, 2017-2031
  • Table 33: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 34: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 35: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Healthcare Industry, 2017-2031
  • Table 36: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
  • Figure 03: Global Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
  • Figure 04: Global Toxicology Drug Testing Market Revenue (US$ Mn), by In Vitro, 2017-2031
  • Figure 05: Global Toxicology Drug Testing Market Revenue (US$ Mn), by In Vivo, 2017-2031
  • Figure 06: Global Toxicology Drug Testing Market Revenue (US$ Mn), by In Silico, 2017-2031
  • Figure 07: Global Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
  • Figure 08: Global Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
  • Figure 09: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Mass Spectrometry Imaging, 2017-2031
  • Figure 10: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Electron Microscopy, 2017-2031
  • Figure 11: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Fluorescence Labeling, 2017-2031
  • Figure 12: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Immunohistochemistry, 2017-2031
  • Figure 13: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 14: Global Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 15: Global Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 16: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Drug Development, 2017-2031
  • Figure 17: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Substance Abuse and Addiction, 2017-2031
  • Figure 18: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Therapeutic Drug Monitoring, 2017-2031
  • Figure 19: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 20: Global Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 21: Global Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 22: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Cosmetics Industry, 2017-2031
  • Figure 23: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Healthcare Industry, 2017-2031
  • Figure 24: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Food Industry, 2017-2031
  • Figure 25: Global Toxicology Drug Testing Market Revenue (US$ Mn), by Chemicals Industry, 2017-2031
  • Figure 26: Global Toxicology Drug Testing Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 27: Global Toxicology Drug Testing Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 28: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 29: North America Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
  • Figure 30: North America Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
  • Figure 31: North America Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
  • Figure 32: North America Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
  • Figure 33: North America Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 34: North America Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 35: North America Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 36: North America Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 37: North America Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 38: North America Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 39: North America Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 40: Europe Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
  • Figure 41: Europe Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
  • Figure 42: Europe Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
  • Figure 43: Europe Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
  • Figure 44: Europe Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 45: Europe Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 46: Europe Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 47: Europe Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 48: Europe Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 49: Europe Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 50: Europe Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 51: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
  • Figure 52: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
  • Figure 53: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
  • Figure 54: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
  • Figure 55: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 56: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 57: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 58: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 59: Asia-Pacific Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 60: Asia-Pacific Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 61: Asia-Pacific Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 62: Latin America Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
  • Figure 63: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
  • Figure 64: Latin America Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
  • Figure 65: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
  • Figure 66: Latin America Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 67: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 68: Latin America Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 69: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 70: Latin America Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 71: Latin America Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 72: Latin America Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 73: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by Testing Type, 2022 and 2031
  • Figure 74: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by Testing Type, 2023-2031
  • Figure 75: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by Testing Method, 2022 and 2031
  • Figure 76: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by Testing Method, 2023-2031
  • Figure 77: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 78: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 79: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 80: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 81: Middle East & Africa Toxicology Drug Testing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 82: Middle East & Africa Toxicology Drug Testing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 83: Middle East & Africa Toxicology Drug Testing Market Value (US$ Mn) Forecast, 2017-2031
目次
Product Code: TMRGL85789

Toxicology Drug Testing Market - Scope of Report

TMR's report on the global toxicology drug testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global toxicology drug testing market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global toxicology drug testing market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the toxicology drug testing market.

Market Snapshot
Market Value in 2023US$ 34.7 Bn
Market Value in 2031US$ 55.7 Bn
CAGR5.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global toxicology drug testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global toxicology drug testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global toxicology drug testing market.

The report delves into the competitive landscape of the global toxicology drug testing market. Key players operating in the global toxicology drug testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global toxicology drug testing market profiled in this report.

Key Questions Answered in Global Toxicology Drug Testing Market Report:

  • What is the sales/revenue generated by toxicology drug testing across all regions during the forecast period?
  • What are the opportunities in the global toxicology drug testing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Toxicology Drug Testing Market - Research Objectives and Research Approach

The comprehensive report on the global toxicology drug testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global toxicology drug testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global toxicology drug testing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Toxicology Drug Testing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Toxicology Drug Testing Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Regulatory Scenario by Region/Globally
  • 5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Toxicology Drug Testing Market Analysis and Forecast, by Testing Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Testing Type, 2017-2031
    • 6.3.1. In Vitro
    • 6.3.2. In Vivo
    • 6.3.3. In Silico
  • 6.4. Market Attractiveness Analysis, by Testing Type

7. Global Toxicology Drug Testing Market Analysis and Forecast, by Testing Method

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Testing Method, 2017-2031
    • 7.3.1. Mass Spectrometry Imaging
    • 7.3.2. Electron Microscopy
    • 7.3.3. Fluorescence Labeling
    • 7.3.4. Immunohistochemistry
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Testing Method

8. Global Toxicology Drug Testing Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Drug Development
    • 8.3.2. Substance Abuse and Addiction
    • 8.3.3. Therapeutic Drug Monitoring
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Toxicology Drug Testing Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Cosmetics Industry
    • 9.3.2. Healthcare Industry
      • 9.3.2.1. Hospital and Clinics
      • 9.3.2.2. Diagnostic Laboratories
      • 9.3.2.3. Pharmaceutical & Biotechnology Companies
      • 9.3.2.4. Others
    • 9.3.3. Food Industry
    • 9.3.4. Chemicals Industry
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Toxicology Drug Testing Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Toxicology Drug Testing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Testing Type, 2017-2031
    • 11.2.1. In Vitro
    • 11.2.2. In Vivo
    • 11.2.3. In Silico
  • 11.3. Market Value Forecast, by Testing Method, 2017-2031
    • 11.3.1. Mass Spectrometry Imaging
    • 11.3.2. Electron Microscopy
    • 11.3.3. Fluorescence Labeling
    • 11.3.4. Immunohistochemistry
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Drug Development
    • 11.4.2. Substance Abuse and Addiction
    • 11.4.3. Therapeutic Drug Monitoring
    • 11.4.4. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Cosmetics Industry
    • 11.5.2. Healthcare Industry
      • 11.5.2.1. Hospital and Clinics
      • 11.5.2.2. Diagnostic Laboratories
      • 11.5.2.3. Pharmaceutical & Biotechnology Companies
      • 11.5.2.4. Others
    • 11.5.3. Food Industry
    • 11.5.4. Chemicals Industry
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Testing Type
    • 11.7.2. By Testing Method
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country/Sub-region

12. Europe Toxicology Drug Testing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Testing Type, 2017-2031
    • 12.2.1. In Vitro
    • 12.2.2. In Vivo
    • 12.2.3. In Silico
  • 12.3. Market Value Forecast, by Testing Method, 2017-2031
    • 12.3.1. Mass Spectrometry Imaging
    • 12.3.2. Electron Microscopy
    • 12.3.3. Fluorescence Labeling
    • 12.3.4. Immunohistochemistry
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Drug Development
    • 12.4.2. Substance Abuse and Addiction
    • 12.4.3. Therapeutic Drug Monitoring
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Cosmetics Industry
    • 12.5.2. Healthcare Industry
      • 12.5.2.1. Hospital and Clinics
      • 12.5.2.2. Diagnostic Laboratories
      • 12.5.2.3. Pharmaceutical & Biotechnology Companies
      • 12.5.2.4. Others
    • 12.5.3. Food Industry
    • 12.5.4. Chemicals Industry
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Testing Type
    • 12.7.2. By Testing Method
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Toxicology Drug Testing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Testing Type, 2017-2031
    • 13.2.1. In Vitro
    • 13.2.2. In Vivo
    • 13.2.3. In Silico
  • 13.3. Market Value Forecast, by Testing Method, 2017-2031
    • 13.3.1. Mass Spectrometry Imaging
    • 13.3.2. Electron Microscopy
    • 13.3.3. Fluorescence Labeling
    • 13.3.4. Immunohistochemistry
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Drug Development
    • 13.4.2. Substance Abuse and Addiction
    • 13.4.3. Therapeutic Drug Monitoring
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Cosmetics Industry
    • 13.5.2. Healthcare Industry
      • 13.5.2.1. Hospital and Clinics
      • 13.5.2.2. Diagnostic Laboratories
      • 13.5.2.3. Pharmaceutical & Biotechnology Companies
      • 13.5.2.4. Others
    • 13.5.3. Food Industry
    • 13.5.4. Chemicals Industry
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Testing Type
    • 13.7.2. By Testing Method
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Toxicology Drug Testing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Testing Type, 2017-2031
    • 14.2.1. In Vitro
    • 14.2.2. In Vivo
    • 14.2.3. In Silico
  • 14.3. Market Value Forecast, by Testing Method, 2017-2031
    • 14.3.1. Mass Spectrometry Imaging
    • 14.3.2. Electron Microscopy
    • 14.3.3. Fluorescence Labeling
    • 14.3.4. Immunohistochemistry
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Drug Development
    • 14.4.2. Substance Abuse and Addiction
    • 14.4.3. Therapeutic Drug Monitoring
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Cosmetics Industry
    • 14.5.2. Healthcare Industry
      • 14.5.2.1. Hospital and Clinics
      • 14.5.2.2. Diagnostic Laboratories
      • 14.5.2.3. Pharmaceutical & Biotechnology Companies
      • 14.5.2.4. Others
    • 14.5.3. Food Industry
    • 14.5.4. Chemicals Industry
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Testing Type
    • 14.7.2. By Testing Method
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Toxicology Drug Testing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Testing Type, 2017-2031
    • 15.2.1. In Vitro
    • 15.2.2. In Vivo
    • 15.2.3. In Silico
  • 15.3. Market Value Forecast, by Testing Method, 2017-2031
    • 15.3.1. Mass Spectrometry Imaging
    • 15.3.2. Electron Microscopy
    • 15.3.3. Fluorescence Labeling
    • 15.3.4. Immunohistochemistry
    • 15.3.5. Others
  • 15.4. Market Value Forecast, by End-user, 2017-2031
    • 15.4.1. Drug Development
    • 15.4.2. Substance Abuse and Addiction
    • 15.4.3. Therapeutic Drug Monitoring
    • 15.4.4. Others
  • 15.5. Market Value Forecast, by Application, 2017-2031
    • 15.5.1. Cosmetics Industry
    • 15.5.2. Healthcare Industry
      • 15.5.2.1. Hospital and Clinics
      • 15.5.2.2. Diagnostic Laboratories
      • 15.5.2.3. Pharmaceutical & Biotechnology Companies
      • 15.5.2.4. Others
    • 15.5.3. Food Industry
    • 15.5.4. Chemicals Industry
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Testing Type
    • 15.7.2. By Testing Method
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. TDAL Labs
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Thermo Fisher Scientific Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Abbott
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Icahn School of Medicine at Mount Sinai
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Clinisys, Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Laboratory Corporation of America Holdings
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. SLUCARE
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Keystone Lab
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Shimadzu Scientific Instruments
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Ganesh Diagnostic & Imaging Centre Pvt. Ltd.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Other Players
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview